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LETTER TO EDITOR
Plasma levels of hsa-miR-3158-3p microRNA on admission
correlate with MRI findings and predict outcome in
cerebral malaria
Dear Editor,
We present here a new microRNA (miRNA) biomarker
for the prognosis of cerebral malaria (CM) that could be
used instead of expensive neuroimaging to monitor dis-
ease severity and progression. Severe Plasmodium falci-
parum malaria (SM) remains a leading cause of mortality
worldwide and is characterized by a combination of
unregulated inflammatory processes and sequestration of
infected erythrocytes (IE) within microvessels. This can
lead to the dysfunction of one or several vital organs, result-
ing in a broad clinical picture.1 CM is an acute neurologic
complication and often fatal form of SM. Prompt diagno-
sis and treatment are the key for a positive outcome but
remain challenging. Recent reports identified age-specific
magnetic resonance imaging (MRI) features on admis-
sion associated with CM fatality, namely brain swelling
in children and decreased apparent diffusion coefficient
(ADC) values indicative of global hypoxia in adults.2,3
Because neuroimaging facilities are rarely accessible in
malaria-endemic countries, we investigated the potential
of miRNAs, which are rapidly released upon organ dam-
age, as biomarkers of such MRI features across different
age groups in a cohort of Indian patients.
We retrospectively analyzed malaria-positive samples
(n = 79) from patients admitted to Ispat General Hospital,
Rourkela, India, between 2013 and 2019. SManduncompli-
cated malaria (UM) patients were defined using the mod-
ified WHO criteria (supplementary materials), and Euro-
pean malaria naïve donors (n = 32) served as healthy
controls (HC). Clinical characteristics of the cohort are
presented in Figure S1 and Table S1. TaqMan-advanced
quantitative reverse transcription PCR (RT-qPCR) assays
were used to measure miRNA levels using 50 μl of plasma
(supplementary materials).4 The selection of miRNAs was
based on published reports (supplementary materials; Fig-
ure S2). Cycle threshold values were <24 in all samples,
with a coefficient of variance < 6% for the exogenous con-
trol (cel-miR-39-3p) amplified by RT-qPCR, indicative of
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a successful cDNA preparation. PCR efficiencies for all
miRNAs had a 91%–106.6% range (Table S2). miRNA levels
were compared in patients with CM alone (CM*), CM and
another concomitant organ involvement (CM+), severe
non-CM (SNCM), UM, and HC. The relative expression
levels (RELs) of hsa-miR-146a-5p, hsa-miR-150-5p, hsa-
miR-222-3p and hsa-miR-3158-3p were significantly higher
in patients with SM (CM, SNCM) compared to UM (p <
0.05; Figure 1). These four miRNAs remained associated
with malaria severity when compared to both UM and HC
or only UM patients (p < 0.05; Figures 2 and S3). A total
of 1670 putative targets engaged in a wide range of biologi-
cal and pathological mechanisms were identified for these
miRNAs, including brain injury, as well as SM-associated
processes and immune responses (supplementary materi-
als, Tables S3 and S4, Figure S4).
However, only hsa-miR-150-5p and hsa-miR-3158-3p
showed significantly higher plasma levels in fatal CM
compared to non-fatal cases (p < 0.05; Figure 2 and S3).
These two miRNAs could also discriminate patients with
fatal CM from non-fatal CM, SNCM, and UM cases, as
well as HC, with AUC of 78%–100%, sensitivity of 80%–
100%, and specificity of 74%–100% (p < 0.05; Table S5).
No significant differences were observed when miRNA
RELs were compared between patients with non-fatal
CM* and CM+ (Figure S5). Of note, both miRNAs were
significantly higher in the plasma of fatal CM+ patients
when compared to survivors (Figure S5). Among the four
miRNAs, hsa-miR-3158-3p RELs significantly decreased
in plasmas collected at Day 30 compared to Day 0 in CM
patients (p = 0.031; Figure S6), strongly suggesting its
cerebral specificity. All enrolled CM patients underwent
MRI scanning as part of a separate project, and imaging
datasets were used to generate quantitative brain volume,
as well as whole-brain ADC maps.2 Using the Spear-
man correlation analysis, we show that hsa-miR-3158-3p
RELs correlated negatively with brain volume (r = -0.89;
p = 0.033) and whole-brain ADC (r = -0.47; p = 0.043)
Clin. Transl. Med. 2021;11:e396. wileyonlinelibrary.com/journal/ctm2 1 of 5
https://doi.org/10.1002/ctm2.396
2 of 5 GUPTA et al.
F IGURE 1 Plasma miRNA levels in SM. Levels of 10 selected miRNAs in plasma samples from Indian patients with SM, including fatal
and non-fatal CM (n = 5 and 37, respectively), non-fatal SNCM (n = 23), were compared to samples from UM patients from the same
population (n = 14). Each miRNA was allocated a color at random to facilitate their identification throughout the manuscript. Relative
expression levels (RELs) were calculated with respect to the mean of two endogenous controls (hsa-miR-30d-5p and hsa-miR-191-5p) and
compared between patients with different malaria severity groups. Statistical differences were obtained from Mann-Whitney U test. T bars
represent median and interquartile ranges. (*p < 0.05, **p < 0.005, ***p < 0.0005)
on admission in children and adults, respectively
(Figure 3).
Previous reports demonstrated that the expression and
levels of circulating human miRNAs are highly sensitive
to physiological and pathological stimuli.5 As a result,
their changes in response to infection by Plasmodium fal-
ciparum raise the possibility of new diagnostic and poten-
tially prognostic tools for SM patients.6 Here, we show that
hsa-miR-3158-3p levels on admission can both discrimi-
nate between SM and UM patients and predict CM fatal-
ity. Our results also suggest that hsa-miR-3158-3p could
be used as a diagnostic tool for severe/cerebral falciparum
malaria across all age groups. In CM patients, we demon-
strate for the first time that plasma hsa-miR-3158-3p lev-
els are negatively correlated with brain volume and whole-
brain ADC values. This indicates that the production of
hsa-miR-3158-3p is decreased in CM patients with high
brain volume on admission, a feature associated with a
poor outcome in children.2,3 Inversely, hsa-miR-3158-3p
levels increased in patients with low global ADC values on
admission, a hallmark of fatal adult CM.2 Such hypoxia-
specific signal in the brain is consistent with the mechani-
cal obstruction of cerebralmicrovessels by sequestered IE,7
which may result in higher hsa-miR-3158-3p production.
Indeed, elevated circulating levels of hsa-miR-3158-3pwere
reported in patients recovering from ischemic stroke.8 Its
expression was also found significantly increased in an in
vitro model of neurodegenerative disorders in response to
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F IGURE 2 Association of miRNA plasma levels with malaria severity and CM fatality. Relative expression levels (RELs) of
hsa-miR-146a-5p, hsa-miR-150-5p, hsa-miR-222-3p, and hsa-miR-3158-3p, all significantly higher in SM patients, were further compared
between (A) patients with different malaria severity groups and European healthy controls (HC) as well as (B) patients with fatal CM and
non-fatal CM. RELs were calculated with respect to the mean of two endogenous controls (hsa-miR-30d-5p and hsa-miR-191-5p) and
compared. Statistical differences were obtained from Mann-Whitney U test. T bars represent median and interquartile ranges. (*p < 0.05,
**p < 0.005, ***p < 0.0005)
Abbreviations: CM, cerebral malaria; UM, uncomplicated malaria; SNCM, severe non-cerebral malaria.
F IGURE 3 Correlation matrices between miRNA and MRI features in CM patients. Spearman’s correlation test was used to assess the
correlation between MRI data and miRNAs in children (≤16 years) (A) and adults (>16 years) (B). The color gradient symbolizes the strength
of correlation for each comparison, and non-significant correlations are marked with a cross
Abbreviations: ADC, apparent diffusion coefficient.
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oxidative stress.9 Hypoxic conditions trigger the produc-
tion of reactive oxygen species and favor oxidative stress,10
potentially further contributing to the high plasma levels of
hsa-miR-3158-3p observed in fatal CM patients. The results
of our clustering analysis confirmed that some of the gene
targets of hsa-miR-3158-3p are involved in hypoxia-related
processes, including HIF-1 signaling (hsa04066), response
to hypoxia (GO:0001666) and cellular response to hypoxia
(GO:0071456). Additional validations of the association
between brain-specific hypoxia and the increased produc-
tion of hsa-miR-3158-3p are needed. Further limitations
include our small sample size, which led to the loss of
significance for some of our candidates when Benjamini-
Hochberg correction was applied (Table S6), and potential
discrepancies in miRNA baselines between European con-
trols and Indian patients. However, this is the first corre-
lation analysis betweenMRI datasets andmiRNA levels in
CM patients, which opens new avenues for prognosis in
this devastating disease.
In conclusion, hsa-miR-3158-3p represents a promis-
ing biomarker candidate for CM prognosis across age
groups that may be considered instead of neuroimaging to
monitor disease progression and, potentially, inform clin-
ical management in the future by helping the selection
of adjunctive treatment targeting brain swelling and/or
hypoxic injury.
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